Beranda › Gangguan Somnolen Berlebih › Colorado
Uji klinis Gangguan Somnolen Berlebih di Colorado
7 studi untuk Gangguan Somnolen Berlebih mencari peserta di lokasi di Colorado.
Kota di Colorado
Teks studi resmi (Bahasa Inggris)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Colorado Springs, Colorado, Colorado Springs
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07598708A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Alpine Clinical Research Center, Inc., Boulder
- Delta Waves LLC, Colorado Springs
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Boulder
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Boulder
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07502443A Study of Pitolisant in Patients With Prader-Willi Syndrome
- Colorado Children's Hospital, Aurora
Menerima pesertaFase 3
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06366464A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Boulder
- Alkermes Investigational Site, Colorado Springs
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06767683Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Colorado Springs
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06568367Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.